Overview of the Final Conference
Brussels, February 9th 2009
(In partnership with biotechnology associations from the Member States, Inserm and EuropaBio.)
Report :
Panel discussion I : Clinical Trials Frameworks, Guidelines, Issues and Recommendations
• Frameworks and Guidelines – Detlef Niese, Novartis, EuropaBio
> clinical trials frameworks and guidelines detlef niese novartis europabio2
• Issues and Recommendations – Anne Dupraz Poiseau, Voisin Consulting, France Biotech
> Clinical trials issues and recommendations anne dupraz poiseau voisin consulting france biotech1
Panel discussion II: Gene and Cell Therapy Frameworks, Guidelines, Issues and Recommendations
• European Frameworks and Guidelines – Maurizio Salvi, European Commission
> Gene and Cell Therapy : European Frameworks and Guidelines – Maurizio Salvi, European Commission
• Issues and Recommendations – David Sourdive, Cellectis, France Biotech
> Gene and Cell Therapy : Issues and Recommendations – David Sourdive, Cellectis, France Biotech
Panel discussion III: Biobanks Frameworks, Guidelines, Issues and Recommendations
• Framework and Guidelines – Emmanuelle Rial-Sebbag, INSERM U558
> Biobanks : Framework and Guidelines – Emmanuelle Rial-Sebbag, INSERM U558
• Issues and Recommendations – Karin Aase, SwedenBIO
> Biobanks : Issues and Recommendations – Karin Aase, SwedenBIO
Panel discussion IV: Genetic testing Frameworks, Guidelines, Issues and Recommendations
• Frameworks and Guidelines – Anne Cambon-Thomsen, INSERM U558
> Biobanks : Issues and Recommendations – Karin Aase, SwedenBIO
• Issues and Recommendations – Eric Tambuyzer, Genzyme, EuropaBio
> Genetic testing : Issues and Recommendations – Eric Tambuyzer, Genzyme, EuropaBio
CORE ETHICAL VALUES presented by Eric Tambuyzer – EuropaBio
> Core Ethical Values : Eric Tambuyzer – EuropaBio
Print 
PDF 
